TITLE: Uracil-tegafur and tamoxifen versus cyclophosphamide, methotrexate, fluorouracil, and tamoxifen in postoperative adjuvant therapy for stage I, II, or IIIA lymph node-positive breast cancer: a comparative study

ABSTRACT 
  ABSTRACT: 

BODY:  xmlns:ns0="http://www.w3.org/1999/xlink">Correction to: British Journal of Cancer (2009) 101, 598â€“604; doi:10.1038/sj.bjc.6605218 www.bjcancer.com  Upon publication of this paper in Volume 101, the authors noticed an error in the data contained within Table 3, taken from their original manuscript. The incidence of alopecia in CMF group should have been 39.3%, not 9.3%. The correct data are now shown, below.